Management of colorectal cancer: a role for genetics in prevention and treatment?
Colorectal cancer remains one of the most common cancers in the Western world and amongst the top three causes of cancer morbidity and death. Cancer is caused by genetic mutations, but currently there is little use of genetic information in the clinic with the exception of establishing germline mutations for the uncommon predisposing syndromes. Rapid advances in technologies allowing high throughput analysis of germline and somatic mutations raises the possibility that genetics will find a major role in the clinic distinguishing individuals at low to high risk of cancer, allowing early intervention and stratification of cancers based on mutational pathways for therapeutic interventions. In the future, this will lead to treatment regimes tailored to the individuals and their tumor. Here, we summarize the genetics underlying colorectal cancer and the future role of genetics in prevention, diagnosis, classification and treatment.
Colorectal Cancer Genetics Group, Institute of Cell, and Molecular Science, Barts and the London School of Medicine and Dentistry, Queen Mary University of London, 4 Newark Street, Whitechapel, London E1 2AT, UK.
Neel
N
Sengupta
Kathryn A
KA
Gill
Tammie S
TS
MacFie
Cecilia S
CS
Lai
Nirosha
N
Suraweera
Sarah
S
Mcdonald
Andrew
A
Silver
D000230:Adenocarcinoma / Q000235:genetics / Q000517:prevention & control / Q000628:therapy; D000236:Adenoma / Q000235:genetics / Q000517:prevention & control / Q000628:therapy; D015179:Colorectal Neoplasms / Q000235:genetics / Q000517:prevention & control / Q000628:therapy; D052138:Genes, Neoplasm / Q000235:genetics; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D042822:Genomic Instability / Q000235:genetics; D006801:Humans; D020641:Polymorphism, Single Nucleotide / Q000235:genetics